Liberty Biopharma (CVE:LTY) Share Price Crosses Above 50-Day Moving Average – Should You Sell?

Liberty Biopharma Inc (CVE:LTY) shares passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.

Liberty Biopharma Stock Performance

The company’s fifty day simple moving average is C$2.00 and its two-hundred day simple moving average is C$2.00. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12. The stock has a market capitalization of C$21.54 million and a P/E ratio of -12.66.

Liberty Biopharma Company Profile

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.